Pathway | Count | p-Value | q-Value | Gene |
---|---|---|---|---|
Cell adhesion molecules (CAMs) | 13 | 9.35E-12 | 6.95E-11 | Cdh1;RT1-N3;Cd8a;Jam3;Itgb7;Cd274;Cldn5;Cd8b; |
Icam2;H2-T24;Itgam;Itgb2;Cldn4 | ||||
Natural killer cell mediated cytotoxicity | 12 | 8.04E-11 | 3.78E-10 | Rac2;RT1-N3;Ptpn6;Lck;Grb2;Zap70;Icam2;H2-T24; |
Tyrobp;Fcgr3;Itgb2;Prf1 | ||||
Focal adhesion | 13 | 1.61E-10 | 6.43E-10 | Rac2;Fn1;Col5a1;Grb2;Itgb7;Fn1;Col1a2;Col1a1; |
Col4a2;Col1a1;Col4a1;Tnn;Flna;Ccnd1;Myl9 | ||||
Complement and coagulation cascades | 9 | 3.42E-10 | 1.27E-09 | C1qb;C4b |
;C1qa;C1r | ||||
;C1s;Cfb; | ||||
C2;C6;Plau | ||||
ECM-receptor interaction | 8 | 1.55E-08 | 3.84E-08 | Fn1;Col5a1;Itgb7;Fn1;Col1a2;Col1a1;Col4a2; |
Col1a1;Col4a1;Tnn | ||||
Leukocyte transendothelial migration | 9 | 4.12E-08 | 8.92E-08 | Rac2;Jam3;Cldn5;Thy1;Itgam;Itgb2;Cxcr4;Myl9;Cldn4 |
Primary immunodeficiency | 6 | 6.53E-08 | 1.36E-07 | Cd8a;Ciita;Lck;Zap70;Rfxap;Cd8b |
Arachidonic acid metabolism | 6 | 1.61E-06 | 2.61E-06 | Ephx2;Cyp2j4;Gpx3;Ptgs1;Pla2g10;Cbr1 |
Systemic lupus erythematosus | 8 | 2.56E-06 | 4.04E-06 | C1qb;C4b;C1qa;C1r;C1s;C2;C6;Fcgr3 |
Antigen processing and presentation | 7 | 2.92E-06 | 4.22E-06 | RT1-N3;Cd8a;Ciita;Rfxap;Cd8b;H2-T24;Cd74 |
Regulation of actin cytoskeleton | 9 | 5.00E-06 | 7.03E-06 | Cfl1;LOC688430;Rac2;Fn1;Pip4k2a;Itgb7;Fn1; |
Itgam;Itgb2;Myl9 | ||||
T cell receptor signaling pathway | 6 | 6.53E-05 | 7.54E-05 | Cd8a;Ptpn6;Lck;Grb2;Zap70;Cd8b |
Hematopoietic cell lineage | 5 | 1.02E-04 | 1.09E-04 | Cd8a;Csf1r;Anpep;Cd8b;Itgam |
Axon guidance | 6 | 1.25E-04 | 1.30E-04 | Cfl1;LOC688430;Rac2;Slit3;Fes;Cxcr4 |
Small cell lung cancer | 5 | 2.92E-04 | 2.62E-04 | Fn1;Nos3;Fn1;Col4a2;Col4a1;Ccnd1 |
Citrate cycle (TCA cycle) | 3 | 7.92E-04 | 6.44E-04 | Pck1;Aco1;Acly |